BioCardia, Inc. (BCDA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, BioCardia, Inc. reported revenue of $0, down 100.0% from the prior year. The company ran a net loss. It held $3.41M in total assets against $2.52M in total liabilities.
Key ratios (FY2025)
-919.3%
Return on equity
-100.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $58.0K | $477.0K | $1.35M | $1.01M | $145.0K | $710.0K | $625.0K | $479.0K | $576.0K |
| Cost of Revenue | — | — | — | — | $0 | $4.0K | $358.0K | $517.0K | $690.0K | $746.0K |
| Operating Income | -$8.28M | -$8.00M | -$11.64M | -$11.90M | -$12.63M | -$15.53M | -$14.21M | -$14.10M | -$12.40M | -$7.61M |
| Net Income | -$8.23M | -$7.95M | -$11.57M | -$11.91M | -$12.62M | -$15.00M | -$14.71M | -$13.99M | -$12.31M | -$10.31M |
| EPS (Diluted) | $-1.23 | $-2.90 | $-8.19 | $-0.67 | $-0.75 | — | — | — | — | — |
| Total Assets | $3.41M | $3.72M | $2.99M | $9.79M | $15.72M | $23.42M | $7.68M | $6.42M | $13.54M | $22.08M |
| Total Liabilities | $2.52M | $2.89M | $4.59M | $4.90M | $5.34M | $4.25M | $5.31M | $2.62M | $2.41M | $1.50M |
| Shareholders' Equity | $895.0K | $837.0K | -$1.60M | $4.89M | $10.38M | $19.18M | $2.37M | $3.79M | $11.12M | $20.58M |
| Cash & Equivalents | $2.50M | $2.37M | $1.10M | $7.36M | $12.87M | $21.41M | $5.58M | $5.36M | $12.69M | $21.35M |
| Operating Cash Flow | -$7.44M | -$7.89M | -$9.97M | -$10.56M | -$10.37M | -$12.36M | -$9.45M | -$11.07M | -$8.67M | -$5.52M |
| Capital Expenditures | $7.0K | $6.0K | $12.0K | $70.0K | $116.0K | $32.0K | $146.0K | $66.0K | $136.0K | — |
| Shares Outstanding | 10.76M | 4.60M | 23.67M | 20.08M | 16.87M | 16.30M | 6.83M | 4.85M | 38.22M | 38.13M |